Catalog No.
KDB94406
Description
PRINCIPLE OF THE ASSAY This assay employs the quantitative competitive enzyme immunoassay technique. Recombinant Human TNFa has been pre-coated onto a microplate. Standards or samples are premixed with biotin-labeled antibody and then pipetted into the wells. Certolizumab Pegol in the sample competitively binds to the pre-coated protein with biotin-labeled Certolizumab Pegol. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in inversely proportion to the amount of Certolizumab Pegol bound in the initial step. The color development is stopped and the intensity of the color is measured.
Applications
Used for the quantitative determination of Certolizumab Pegol concentration in serum and plasma.
Reconstitution
When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%.
Range
468.75 - 30,000 ng/mL
Sensitivity
346.21 ng/mL
Precision
Intra-Assay Precision (Precision within an assay): <20%
Three samples of known concentration were tested sixteen times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): <20%
Three samples of known concentration were tested in twenty four separate assays to assess inter-assay precision.
For research use only. Not for human or drug use.
